Watson Pharmaceuticals has won US antitrust approval to buy Swiss firm Actavis Inc but only with certain conditions, the Federal Trade Commission (FTC) announced yesterday. Watson Pharmaceuticals ...

For Actavis, the new approval helps it extend its presence in the field – having bought Durata Therapeutics along with its recently approved antibiotic Dalvance (dalbavancin) in October.

Following its acquisition of Actavis, Teva now has around 340 product registrations pending FDA approval and holds the leading position in first-to-file opportunities, with approximately 115 ...

Counsel have not yet appeared for the defendants. The case is 3:23-cv-03298, Providence St. Joseph Health et al v. Actavis Holdco US, Inc. et al.